Early Breast Cancer Terminated Phase 2 Trials for Talazoparib (DB11760)

Also known as: Stage I Breast Carcinoma / Early-Stage Breast Cancer / Stage I Breast Cancer / Carcinoma breast stage I / Breast cancer stage I / Breast carcinoma stage I / Breast carcinoma NOS stage I / Breast cancer NOS stage I

IndicationStatusPhase
DBCOND0034800 (Early Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03499353Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast CancerTreatment